Altered neuropeptide concentrations in spontaneously hypertensive rats: cause or consequence?

Area of Science:

• Neuroscience
• Endocrinology
• Cardiovascular Research

Background:

• Hypertension can alter brain neuropeptide levels.
• Stroke-prone spontaneously hypertensive rats (SHRSP) exhibit distinct physiological changes.
• Understanding neuropeptide involvement is crucial for hypertension research.

Purpose of the Study:

• To investigate brain neuropeptide concentrations (beta-endorphin, Leu-enkephalin, arginine vasopressin (AVP), and oxytocin (OXT)) in SHRSP.
• To determine if these changes are a cause or consequence of hypertension.
• To assess the effect of chronic antihypertensive treatment with clonidine on neuropeptide levels.

Main Methods:

• Measurement of beta-endorphin, Leu-enkephalin, AVP, and OXT in various brain regions and adrenal glands of SHRSP and Wistar Kyoto (WKY) rats.
• Analysis of peptide content in 12-, 18-, and 24-week-old rats.
• Comparison of peptide levels in SHRSP before and after chronic clonidine treatment to normalize blood pressure.

Main Results:

• Elevated beta-endorphin in the pituitary neuro-intermediate lobe of young SHRSP.
• Reduced adrenal gland Leu-enkephalin in SHRSP compared to WKY rats.
• Markedly decreased OXT and AVP in most brain regions of SHRSP, with no change in the pituitary neuro-intermediate lobe.
• Clonidine treatment did not reverse the altered neuropeptide concentrations in SHRSP.

Conclusions:

• Alterations in brain neuropeptide content in SHRSP are primary, not secondary to hypertension.
• The blood pressure-lowering effect of clonidine is independent of significant changes in these neuropeptide concentrations.
• A genetic defect in the synthesis of adrenal enkephalins and hypothalamic OXT and AVP is suggested.